Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Biocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...

As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

Why are Dow Jones and S&P 500 in red while Nasdaq turns green today? The US stock market futures today are sending a sharp, layered signal....

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

India's drug companies face a tough race in the global biologics market. China is quickly becoming a leader in biotech supply chains. India...

Union Minister J P Nadda urged India's pharmaceutical industry to lead global supply chains with quality and innovation. India is embracing...

During his visit to India, the US National Security Advisor emphasized the importance of US-India collaboration to tackle China's predatori...

Economic Survey 2024: The domestic pharmaceutical industry in India needs skill advancement, innovation, and a robust supply chain to meet ...

In the Interim Budget, Finance Minister Nirmala Sitharaman introduced financial assistance for the procurement of biomass aggregation machi...

The mRNA-based vaccine was developed by Gennova Biopharmaceuticals using the indigenous platform technology, and supported under the Missio...

Granules, which was one of the first Indian pharmaceutical companies that received FDA authorization to export to the United States, has in...

Gennova Biopharmaceuticals submitted the data in the month of April followed by additional data in the month of May. Earlier last month, in...

South Korea's top conglomerate said on Tuesday the investments through 2026 are expected to help Samsung drive long-term growth in strategi...

The experimental monoclonal antibodies therapy, called AZD7442, reduced the risk of severe COVID-19 or death by half in non-hospitalised pa...

Mumbai-based VAV Lifesciences is the only domestic firm in the COVID-19 vaccine supply chain with this crucial ingredient. It can thus can ...

As per the terms of the proposed agreement, ADQ will invest Rs 555 Crore for a 1.80 per cent minority stake in the biosimilar business, val...